Cargando…
Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer
BACKGROUND: It remains unknown to what extent consensus molecular subtype (CMS) groups and immune-stromal infiltration patterns improve our ability to predict outcomes over tumor–node–metastasis (TNM) staging and microsatellite instability (MSI) status in early-stage colorectal cancer (CRC). PATIENT...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857614/ https://www.ncbi.nlm.nih.gov/pubmed/31504112 http://dx.doi.org/10.1093/annonc/mdz287 |
_version_ | 1783470802670190592 |
---|---|
author | Dienstmann, R Villacampa, G Sveen, A Mason, M J Niedzwiecki, D Nesbakken, A Moreno, V Warren, R S Lothe, R A Guinney, J |
author_facet | Dienstmann, R Villacampa, G Sveen, A Mason, M J Niedzwiecki, D Nesbakken, A Moreno, V Warren, R S Lothe, R A Guinney, J |
author_sort | Dienstmann, R |
collection | PubMed |
description | BACKGROUND: It remains unknown to what extent consensus molecular subtype (CMS) groups and immune-stromal infiltration patterns improve our ability to predict outcomes over tumor–node–metastasis (TNM) staging and microsatellite instability (MSI) status in early-stage colorectal cancer (CRC). PATIENTS AND METHODS: We carried out a comprehensive retrospective biomarker analysis of prognostic markers in adjuvant chemotherapy-untreated (N = 1656) and treated (N = 980), stage II (N = 1799) and III (N = 837) CRCs. We defined CMS scores and estimated CD8+ cytotoxic lymphocytes (CytoLym) and cancer-associated fibroblasts (CAF) infiltration scores from bulk tumor tissue transcriptomes (CMSclassifier and MCPcounter R packages); constructed a stratified multivariable Cox model for disease-free survival (DFS); and calculated the relative proportion of explained variation by each marker (clinicopathological [ClinPath], genomics [Gen: MSI, BRAF and KRAS mutations], CMS scores [CMS] and microenvironment cells [MicroCells: CytoLym+CAF]). RESULTS: In multivariable models, only ClinPath and MicroCells remained significant prognostic factors, with both CytoLym and CAF infiltration scores improving survival prediction beyond other markers. The explained variation for DFS models of ClinPath, MicroCells, Gen markers and CMS4 scores was 77%, 14%, 5.3% and 3.7%, respectively, in stage II; and 55.9%, 35.1%, 4.1% and 0.9%, respectively, in stage III. Patients whose tumors were CytoLym high/CAF low had better DFS than other strata [HR=0.71 (0.6–0.9); P = 0.004]. Microsatellite stable tumors had the strongest signal for improved outcomes with CytoLym high scores (interaction P = 0.04) and the poor prognosis linked to high CAF scores was limited to stage III disease (interaction P = 0.04). CONCLUSIONS: Our results confirm that tumor microenvironment infiltration patterns represent potent determinants of the risk for distant dissemination in early-stage CRC. Multivariable models suggest that the prognostic value of MSI and CMS groups is largely explained by CytoLym and CAF infiltration patterns. |
format | Online Article Text |
id | pubmed-6857614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68576142019-11-20 Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer Dienstmann, R Villacampa, G Sveen, A Mason, M J Niedzwiecki, D Nesbakken, A Moreno, V Warren, R S Lothe, R A Guinney, J Ann Oncol Original Articles BACKGROUND: It remains unknown to what extent consensus molecular subtype (CMS) groups and immune-stromal infiltration patterns improve our ability to predict outcomes over tumor–node–metastasis (TNM) staging and microsatellite instability (MSI) status in early-stage colorectal cancer (CRC). PATIENTS AND METHODS: We carried out a comprehensive retrospective biomarker analysis of prognostic markers in adjuvant chemotherapy-untreated (N = 1656) and treated (N = 980), stage II (N = 1799) and III (N = 837) CRCs. We defined CMS scores and estimated CD8+ cytotoxic lymphocytes (CytoLym) and cancer-associated fibroblasts (CAF) infiltration scores from bulk tumor tissue transcriptomes (CMSclassifier and MCPcounter R packages); constructed a stratified multivariable Cox model for disease-free survival (DFS); and calculated the relative proportion of explained variation by each marker (clinicopathological [ClinPath], genomics [Gen: MSI, BRAF and KRAS mutations], CMS scores [CMS] and microenvironment cells [MicroCells: CytoLym+CAF]). RESULTS: In multivariable models, only ClinPath and MicroCells remained significant prognostic factors, with both CytoLym and CAF infiltration scores improving survival prediction beyond other markers. The explained variation for DFS models of ClinPath, MicroCells, Gen markers and CMS4 scores was 77%, 14%, 5.3% and 3.7%, respectively, in stage II; and 55.9%, 35.1%, 4.1% and 0.9%, respectively, in stage III. Patients whose tumors were CytoLym high/CAF low had better DFS than other strata [HR=0.71 (0.6–0.9); P = 0.004]. Microsatellite stable tumors had the strongest signal for improved outcomes with CytoLym high scores (interaction P = 0.04) and the poor prognosis linked to high CAF scores was limited to stage III disease (interaction P = 0.04). CONCLUSIONS: Our results confirm that tumor microenvironment infiltration patterns represent potent determinants of the risk for distant dissemination in early-stage CRC. Multivariable models suggest that the prognostic value of MSI and CMS groups is largely explained by CytoLym and CAF infiltration patterns. Oxford University Press 2019-10 2019-08-27 /pmc/articles/PMC6857614/ /pubmed/31504112 http://dx.doi.org/10.1093/annonc/mdz287 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Articles Dienstmann, R Villacampa, G Sveen, A Mason, M J Niedzwiecki, D Nesbakken, A Moreno, V Warren, R S Lothe, R A Guinney, J Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer |
title | Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer |
title_full | Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer |
title_fullStr | Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer |
title_full_unstemmed | Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer |
title_short | Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer |
title_sort | relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage ii/iii colorectal cancer |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857614/ https://www.ncbi.nlm.nih.gov/pubmed/31504112 http://dx.doi.org/10.1093/annonc/mdz287 |
work_keys_str_mv | AT dienstmannr relativecontributionofclinicopathologicalvariablesgenomicmarkerstranscriptomicsubtypingandmicroenvironmentfeaturesforoutcomepredictioninstageiiiiicolorectalcancer AT villacampag relativecontributionofclinicopathologicalvariablesgenomicmarkerstranscriptomicsubtypingandmicroenvironmentfeaturesforoutcomepredictioninstageiiiiicolorectalcancer AT sveena relativecontributionofclinicopathologicalvariablesgenomicmarkerstranscriptomicsubtypingandmicroenvironmentfeaturesforoutcomepredictioninstageiiiiicolorectalcancer AT masonmj relativecontributionofclinicopathologicalvariablesgenomicmarkerstranscriptomicsubtypingandmicroenvironmentfeaturesforoutcomepredictioninstageiiiiicolorectalcancer AT niedzwieckid relativecontributionofclinicopathologicalvariablesgenomicmarkerstranscriptomicsubtypingandmicroenvironmentfeaturesforoutcomepredictioninstageiiiiicolorectalcancer AT nesbakkena relativecontributionofclinicopathologicalvariablesgenomicmarkerstranscriptomicsubtypingandmicroenvironmentfeaturesforoutcomepredictioninstageiiiiicolorectalcancer AT morenov relativecontributionofclinicopathologicalvariablesgenomicmarkerstranscriptomicsubtypingandmicroenvironmentfeaturesforoutcomepredictioninstageiiiiicolorectalcancer AT warrenrs relativecontributionofclinicopathologicalvariablesgenomicmarkerstranscriptomicsubtypingandmicroenvironmentfeaturesforoutcomepredictioninstageiiiiicolorectalcancer AT lothera relativecontributionofclinicopathologicalvariablesgenomicmarkerstranscriptomicsubtypingandmicroenvironmentfeaturesforoutcomepredictioninstageiiiiicolorectalcancer AT guinneyj relativecontributionofclinicopathologicalvariablesgenomicmarkerstranscriptomicsubtypingandmicroenvironmentfeaturesforoutcomepredictioninstageiiiiicolorectalcancer |